Universal Health Services (UHS)

NYSE:UHS

UHS

Universal Health

RESEARCH TOOLSreports

Want to see UHS full AI Analyst Report?

Universal Health (UHS) Stock Forecast & Price Target

568 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UHS Analyst Ratings

Moderate Buy

5 Buy

7 Hold

1 Sell

Based on 13 analysts giving stock ratings to

Universal

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UHS Stock 12 Month Forecast

Average Price Target

$225.92

▲(23.85% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Universal Health in the last 3 months. The average price target is $225.92 with a high forecast of $310.00 and a low forecast of $190.00. The average price target represents a 23.85% change from the last price of $182.41.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"161":"$161","236":"$236","311":"$311","198.5":"$198.5","273.5":"$273.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":310,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$310.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":225.91666666666666,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$225.92</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":190,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$190.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[161,198.5,236,273.5,311],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,167,178,189,200,211,222,233,244,255,266,277,288,299,{"y":310,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,167,171.53205128205127,176.06410256410257,180.59615384615384,185.12820512820514,189.6602564102564,194.19230769230768,198.72435897435898,203.25641025641025,207.78846153846155,212.32051282051282,216.8525641025641,221.38461538461536,{"y":225.91666666666666,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,167,168.76923076923077,170.53846153846155,172.30769230769232,174.07692307692307,175.84615384615384,177.6153846153846,179.3846153846154,181.15384615384616,182.92307692307693,184.69230769230768,186.46153846153845,188.23076923076923,{"y":190,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":173.942,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":186.838,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.393,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.508,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181.055,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":203.145,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":216.621,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":239.197,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":217.808,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201.664,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.42,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.94,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":167,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$310.00

Average Price Target$225.92

Lowest Price Target$190.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Kevin Fischbeck

Bank of America Securities

$215

Sell

17.87%

Upside

Reiterated

05/12/26

Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (NASDAQ: CCCC), McKesson (NYSE: MCK) and Universal Health (NYSE: UHS)

A.J. Rice

UBS

$320→$310

Buy

69.95%

Upside

Assigned

04/30/26

Analysts Are Bullish on These Healthcare Stocks: Universal Health (UHS), Glaukos (GKOS)

John Ransom

Raymond James

―

Hold

―

Downgraded

04/29/26

Universal Health downgraded to Market Perform from Outperform at Raymond JamesUniversal Health downgraded to Market Perform from Outperform at Raymond James

Ann Hynes

Mizuho Securities

$230

Buy

26.09%

Upside

Reiterated

04/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Universal Health (NYSE: UHS), Viking Therapeutics (NASDAQ: VKTX) and Regeneron (NASDAQ: REGN)

Sarah James

Cantor Fitzgerald

$229→$194

Hold

6.35%

Upside

Reiterated

04/29/26

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE), Universal Health (NYSE: UHS) and Pfizer (NYSE: PFE)

Ben Hendrix

RBC Capital

$216→$190

Hold

4.16%

Upside

Reiterated

04/29/26

Universal Health price target lowered to $190 from $216 at RBC CapitalUniversal Health price target lowered to $190 from $216 at RBC Capital

Michael Ha

Robert W. Baird

$241→$204

Hold

11.84%

Upside

Reiterated

04/29/26

Universal Health price target lowered to $204 from $241 at BairdUniversal Health price target lowered to $204 from $241 at Baird

Ryan Langston

TD Cowen

$245→$230

Buy

26.09%

Upside

Assigned

04/29/26

Analysts Offer Insights on Healthcare Companies: Nautilus Biotechnolgy (NASDAQ: NAUT) and Universal Health (NYSE: UHS)

Scott Fidel

Goldman Sachs

$242

Hold

32.67%

Upside

Reiterated

04/28/26

Universal Health Maintained at Hold as Q1 Beat Driven by Pricing Strength but Volume Trends Remain Soft

Jason Cassorla

Guggenheim

$238→$211

Buy

15.67%

Upside

Reiterated

04/28/26

Universal Health (UHS) Gets a Buy from Guggenheim

Andrew Mok CFA

Barclays

$268→$238

Buy

30.48%

Upside

Assigned

04/28/26

Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS) and Qiagen (NYSE: QGEN)

Benjamin Rossi

J.P. Morgan

$235

Hold

28.83%

Upside

Reiterated

03/17/26

Analysts Conflicted on These Healthcare Names: Cochlear (Other OTC: CHEOF), Universal Health (NYSE: UHS) and Vera Therapeutics (NASDAQ: VERA)

Stephen Baxter

Wells Fargo

$235→$212

Hold

16.22%

Upside

Reiterated

03/02/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Vaxcyte (NASDAQ: PCVX), Universal Health (NYSE: UHS) and MoonLake Immunotherapeutics (NASDAQ: MLTX)

Craig Hettenbach

Morgan Stanley

$200→$233

Hold

27.73%

Upside

Reiterated

10/29/25

Universal Health's Mixed Q3 Performance and Stable Outlook Justify Hold Rating

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Kevin Fischbeck

Bank of America Securities

$215

Sell

17.87%

Upside

Reiterated

05/12/26

Analysts Offer Insights on Healthcare Companies: C4 Therapeutics (NASDAQ: CCCC), McKesson (NYSE: MCK) and Universal Health (NYSE: UHS)

A.J. Rice

UBS

$320→$310

Buy

69.95%

Upside

Assigned

04/30/26

Analysts Are Bullish on These Healthcare Stocks: Universal Health (UHS), Glaukos (GKOS)

John Ransom

Raymond James

―

Hold

―

Downgraded

04/29/26

Universal Health downgraded to Market Perform from Outperform at Raymond JamesUniversal Health downgraded to Market Perform from Outperform at Raymond James

Ann Hynes

Mizuho Securities

$230

Buy

26.09%

Upside

Reiterated

04/29/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Universal Health (NYSE: UHS), Viking Therapeutics (NASDAQ: VKTX) and Regeneron (NASDAQ: REGN)

Sarah James

Cantor Fitzgerald

$229→$194

Hold

6.35%

Upside

Reiterated

04/29/26

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (NASDAQ: WVE), Universal Health (NYSE: UHS) and Pfizer (NYSE: PFE)

Ben Hendrix

RBC Capital

$216→$190

Hold

4.16%

Upside

Reiterated

04/29/26

Universal Health price target lowered to $190 from $216 at RBC CapitalUniversal Health price target lowered to $190 from $216 at RBC Capital

Michael Ha

Robert W. Baird

$241→$204

Hold

11.84%

Upside

Reiterated

04/29/26

Universal Health price target lowered to $204 from $241 at BairdUniversal Health price target lowered to $204 from $241 at Baird

Ryan Langston

TD Cowen

$245→$230

Buy

26.09%

Upside

Assigned

04/29/26

Analysts Offer Insights on Healthcare Companies: Nautilus Biotechnolgy (NASDAQ: NAUT) and Universal Health (NYSE: UHS)

Scott Fidel

Goldman Sachs

$242

Hold

32.67%

Upside

Reiterated

04/28/26

Universal Health Maintained at Hold as Q1 Beat Driven by Pricing Strength but Volume Trends Remain Soft

Jason Cassorla

Guggenheim

$238→$211

Buy

15.67%

Upside

Reiterated

04/28/26

Universal Health (UHS) Gets a Buy from Guggenheim

Andrew Mok CFA

Barclays

$268→$238

Buy

30.48%

Upside

Assigned

04/28/26

Analysts Offer Insights on Healthcare Companies: Universal Health (NYSE: UHS) and Qiagen (NYSE: QGEN)

Benjamin Rossi

J.P. Morgan

$235

Hold

28.83%

Upside

Reiterated

03/17/26

Analysts Conflicted on These Healthcare Names: Cochlear (Other OTC: CHEOF), Universal Health (NYSE: UHS) and Vera Therapeutics (NASDAQ: VERA)

Stephen Baxter

Wells Fargo

$235→$212

Hold

16.22%

Upside

Reiterated

03/02/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Vaxcyte (NASDAQ: PCVX), Universal Health (NYSE: UHS) and MoonLake Immunotherapeutics (NASDAQ: MLTX)

Craig Hettenbach

Morgan Stanley

$200→$233

Hold

27.73%

Upside

Reiterated

10/29/25

Universal Health's Mixed Q3 Performance and Stable Outlook Justify Hold Rating

Matthew Gillmor CFA

KeyBanc

―

Hold

―

Reiterated

10/28/25

KeyBanc Remains a Hold on Universal Health (UHS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

TRAXFirst Tracks Biotherapeutics Inc

EVMNEvommune, Inc.

MPLTMapLight Therapeutics, Inc.

MAZEMaze Therapeutics, Inc.

AAPGAscentage Pharma Group International Unsponsored ADR

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Universal Health

3 Months

Andrew Mok CFABarclays

Success Rate

13/19 ratings generated profit

Average Return

+1.32%

Copying Andrew Mok CFA's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +1.32% per trade.

1 Year

Kevin FischbeckBank of America Securities

Success Rate

14/20 ratings generated profit

Average Return

+12.48%

Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +12.48% per trade.

2 Years

Ann HynesMizuho Securities

Success Rate

20/29 ratings generated profit

Average Return

+20.68%

Copying Ann Hynes's trades and holding each position for 2 Years would result in 68.97% of your transactions generating a profit, with an average return of +20.68% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UHS Analyst Recommendation Trends

Rating

Jan 26

Feb 26

Mar 26

Apr 26

May 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UHS has received 8 Buy Ratings, 8 Hold Ratings, and 2 Sell Ratings. UHS average Analyst price target in the past 3 months is 225.92.

Each month's total comprises the sum of three months' worth of ratings.

UHS Financial Forecast

UHS Earnings Forecast

Next quarter’s earnings estimate for UHS is $5.86 with a range of $5.54 to $7.17. The previous quarter’s EPS was $5.62. UHS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year UHS has Performed in-line its overall industry.

UHS Sales Forecast

Next quarter’s sales forecast for UHS is $4.56B with a range of $4.36B to $4.79B. The previous quarter’s sales results were $4.50B. UHS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year UHS has Performed in-line its overall industry.

UHS Stock Forecast FAQ

What is UHS’s average 12-month price target, according to analysts?

Based on analyst ratings, Universal Health Services’s 12-month average price target is 225.92.

What is UHS’s upside potential, based on the analysts’ average price target?

Universal Health Services has 23.85% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UHS a Buy, Sell or Hold?

Universal Health Services has a consensus rating of Moderate Buy which is based on 5 buy ratings, 7 hold ratings and 1 sell ratings.

What is Universal Health Services’s price target?

The average price target for Universal Health Services is 225.92. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $310.00 ,the lowest forecast is $190.00. The average price target represents 23.85% Increase from the current price of $182.41.

What do analysts say about Universal Health Services?

Universal Health Services’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of UHS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Universal Health (UHS) Stock Forecast & Price Target

UHS Analyst Ratings

UHS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Universal Health

UHS Analyst Recommendation Trends

UHS Financial Forecast

UHS Earnings Forecast

UHS Sales Forecast

UHS Stock Forecast FAQ

Detailed List of Analyst Forecasts